Why the study?
Only a few monovalent EV71 vaccines have been developed while other enterovirus vaccines remain in short supply, prompting an exploration of epidemiological characteristics, laboratory diagnosis, clinical signs, and risk factors for hand, foot and mouth disease.
What are the epidemiological characteristics, clinical signs, and risk factors associated with severity and mortality in hand, foot and mouth disease?
What are the epidemiological characteristics, clinical signs, and risk factors associated with severity and mortality in hand, foot and mouth disease?
Clinical signs such as hypersomnia, convulsion, limb shaking, and breathlessness, along with specific laboratory changes, are strong predictors of severity and mortality in hand, foot and mouth disease.
Answers are grounded in this paper and cite their sources.
These signs may enable early risk stratification in HFMD; leaves open prospective validation of predictive models.
BACKGROUND: For the past few years, only a few monovalent EV71 vaccines have been developed, while other enterovirus vaccines are in short supply. We conducted a quantitative meta-analysis to explore the epidemiological characteristics, routine laboratory diagnosis, clinical signs and risk factors for hand, foot and mouth disease (HFMD). METHODS: PubMed, Embase and the Web of Science were searched for eligible reports published before April 16, 2021, with no publication time or language restrictions. The primary outcome was the odds ratio of the epidemiological characteristics, routine laboratory diagnosis, and clinical signs associated with HFMD severity and death. RESULTS: After screening 10522 records, we included 32 articles comprising 781903 cases of hand, foot and mouth disease. Patients with severe illness developed some clinical signs (hypersomnia (OR = 21.97, 95% CI: 4.13 to 116.74), convulsion (OR = 16.18, 95% CI: 5.30 to 49.39), limb shaking (OR = 47.96, 95% CI: 15.17 to 151.67), and breathlessness (OR = 7.48, 95% CI: 1.90 to 29.40)) and had some changes in laboratory parameters (interleukin-6 levels standardized mean difference (SMD) = 1.57, 95%CI: 0.55 to 2.60), an increased neutrophils ratio (SMD = 0.55, 95%CI: 0.17 to 0.93), cluster of differentiation 4 (CD4+) (SMD = -1.38, 95%CI: -2.33 to -0.43) and a reduced lymphocytes ratio (SMD = -0.48, 95%CI: -0.93 to -0.33)) compared with patients with mild illness. The risk factors for death included cyanosis (OR = 5.82, 95% CI: 2.29 to 14.81), a fast heart rate (OR = 3.22, 95% CI: 1.65 to 6.30), vomiting (OR = 2.70, 95% CI: 1.33 to 5.49) and an increased WBC count (SMD = 0.60, 95% CI: 0.27 to 0.93). CONCLUSIONS: China has the highest incidence of HFMD. Our meta-analyses revealed important risk factors that are associated with the severity and mortality of HFMD.
No takes yet. Share an insight, caveat, or question.
Yi et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: